Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial
- PMID: 27217217
- DOI: 10.1093/cid/ciw346
Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial
Abstract
Background: Rotavirus is the world's leading cause of childhood diarrheal death. Despite successes, oral rotavirus vaccines are less effective in developing countries. In an urban slum of Dhaka, we performed active diarrhea surveillance to evaluate monovalent G1P[8] rotavirus vaccine (RV1) efficacy and understand variables contributing to risk of rotavirus diarrhea (RVD).
Methods: We performed a randomized controlled trial of monovalent oral rotavirus vaccine (RV1). Seven hundred healthy infants received RV1 or no RV1 (1:1) using delayed dosing (10 and 17 weeks) and were followed for 1 year. Intensive diarrhea surveillance was performed. The primary outcome was ≥1 episode of RVD. Nutritional, socioeconomic, and immunologic factors were assessed by logistic regression best-subsets analysis for association with risk of RVD and interactions with vaccine arm.
Results: Incidence of all RVD was 38.3 cases per 100 person-years. Per-protocol RV1 efficacy was 73.5% (95% confidence interval [CI], 45.8%-87.0%) against severe RVD and 51% (95% CI, 33.8%-63.7%) against all RVD. Serum zinc level (odds ratio [OR], 0.77; P = .002) and lack of rotavirus immunoglobulin A (IgA) seroconversion (OR, 1.95; P = .018) were associated with risk of RVD, independent of vaccination status. Water treatment and exclusive breastfeeding were of borderline significance. Factors not associated with RVD included height for age at 10 weeks, vitamin D, retinol binding protein, maternal education, household income, and sex.
Conclusions: In an urban slum with high incidence of RVD, the efficacy of RV1 against severe RVD was higher than anticipated in the setting of delayed dosing. Lower serum zinc level and lack of IgA seroconversion were associated with increased risk of RVD independent of vaccination.
Clinical trials registration: NCT01375647.
Keywords: developing countries; oral vaccine; rotavirus diarrhea; underperformance; zinc.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.
Similar articles
-
Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial.PLoS One. 2015 Jun 2;10(6):e0127622. doi: 10.1371/journal.pone.0127622. eCollection 2015. PLoS One. 2015. PMID: 26035743 Free PMC article. Clinical Trial.
-
Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.Clin Infect Dis. 2018 Jul 2;67(2):186-192. doi: 10.1093/cid/ciy076. Clin Infect Dis. 2018. PMID: 29394355 Free PMC article. Clinical Trial.
-
Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.Vaccine. 2015 Dec 16;33(51):7307-7314. doi: 10.1016/j.vaccine.2015.10.118. Epub 2015 Nov 3. Vaccine. 2015. PMID: 26546262
-
Update on Rotarix: an oral human rotavirus vaccine.Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Expert Rev Vaccines. 2009. PMID: 19943758 Review.
-
Pentavalent human-bovine reassortant rotavirus vaccine: a review of its efficacy and safety in preventing acute rotavirus gastroenteritis in healthy infants.Drugs Today (Barc). 2006 May;42(5):313-9. doi: 10.1358/dot.2006.42.5.973591. Drugs Today (Barc). 2006. PMID: 16801994 Review.
Cited by
-
Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality.Vaccines (Basel). 2022 Feb 23;10(3):346. doi: 10.3390/vaccines10030346. Vaccines (Basel). 2022. PMID: 35334978 Free PMC article. Review.
-
Increased Fecal Lactobacillus Is Associated With a Positive Glucose Hydrogen Breath Test in Bangladeshi Children.Open Forum Infect Dis. 2019 Jun 1;6(7):ofz266. doi: 10.1093/ofid/ofz266. eCollection 2019 Jul. Open Forum Infect Dis. 2019. PMID: 31281862 Free PMC article.
-
Vaccines for preventing rotavirus diarrhoea: vaccines in use.Cochrane Database Syst Rev. 2019 Mar 25;3(3):CD008521. doi: 10.1002/14651858.CD008521.pub4. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2019 Oct 28;2019(10). doi: 10.1002/14651858.CD008521.pub5. PMID: 30912133 Free PMC article. Updated.
-
Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.Expert Rev Vaccines. 2017 Oct;16(10):987-995. doi: 10.1080/14760584.2017.1371595. Epub 2017 Sep 4. Expert Rev Vaccines. 2017. PMID: 28832219 Free PMC article. Review.
-
Impact of Rotavirus Vaccine Introduction and Postintroduction Etiology of Diarrhea Requiring Hospital Admission in Haydom, Tanzania, a Rural African Setting.Clin Infect Dis. 2017 Oct 1;65(7):1144-1151. doi: 10.1093/cid/cix494. Clin Infect Dis. 2017. PMID: 28575304 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous